jevtana® (cabazitaxel) mechanism of action
Published 3 years ago • 628 plays • Length 9:41Download video MP4
Download video MP3
Similar videos
-
2:10
jevtana (cabazitaxel)- prostate cancer
-
3:12
cabazitaxel (jevtana) for progressive metastatic prostate cancer after taxotere
-
0:16
cabazitaxel - jevtana in a nutshell
-
12:06
jevtana
-
1:30
cabazitaxel impacts sequencing strategies in prostate cancer
-
7:09
cabazitaxel use in metastatic prostate cancer
-
1:37
cabazitaxel rechallenge in patients with metastatic castration resistant prostate cancer
-
4:31
taxotere vs. jevtana - chemotherapy for prostate cancer | ask a prostate expert, mark scholz, md
-
1:22
cabazitaxel improves rpfs in patients with mcrpc
-
0:34
discussing the safety profile of cabazitaxel in mcrpc
-
3:13
treatment options in metastatic prostate cancer
-
1:33
dr. oh discusses the utility of cabazitaxel
-
2:04
a phase ii trial investigating neoadjuvant abiraterone and cabazitaxel in high-risk prostate cancer
-
0:34
jevtana’s toxicity profile makes it a good option in metastatic prostate cancer
-
2:32
dr. sweeney on the optimal use of cabazitaxel
-
1:04
dr. grivas on potential combinations with cabazitaxel in prostate cancer
-
8:32
how to use jevtana vial - explain uses,side effects,interactions
-
6:42
titan trial
-
2:37
therap: cabazitaxel versus 177lu-psma-617 for mcrpc